Evaluation of the Neuropathic Component of Chronic Low Back Pain

被引:15
|
作者
Andrasinova, Tereza [1 ,2 ]
Kalikova, Eva [1 ,2 ]
Kopacik, Roman [1 ,2 ]
Srotova, Iva [1 ,2 ,3 ]
Vlckova, Eva [1 ,2 ,3 ]
Dusek, Ladislav [4 ]
Bednarik, Josef [1 ,2 ,3 ]
Adamova, Blanka [1 ,2 ,3 ]
机构
[1] Univ Hosp, Dept Neurol, Jihlavska 20, Brno 62500, Czech Republic
[2] Masaryk Univ, Jihlavska 20, Brno 62500, Czech Republic
[3] Masaryk Univ, CEITEC Cent European Inst Technol, Fac Med, Brno, Czech Republic
[4] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic
来源
CLINICAL JOURNAL OF PAIN | 2019年 / 35卷 / 01期
关键词
neuropathic pain; low back pain; quantitative sensory testing; questionnaire; skin biopsy; NERVE-FIBER DENSITY; SKIN BIOPSY; SCREENING QUESTIONNAIRES; GRADING SYSTEM; PAINDETECT; PHENOTYPE; DIAGNOSIS; VALIDITY; LEG;
D O I
10.1097/AJP.0000000000000653
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Assessment of neuropathic pain in chronic low back syndromes is important. However, there is currently no gold standard for its diagnosis. The aim of this observational cross-sectional study was to assess the neuropathic component of pain in various chronic low back pain syndromes using a range of diagnostic tests. Materials and Methods: Included in this study were 63 patients with chronic axial low back pain (ALBP), 48 patients with chronic radicular syndromes (CRS) comprising 23 with discogenic compression (CDRS) and 25 with lumbar spinal stenosis (LSS), and 74 controls. PainDETECT questionnaire (PDQ), quantitative sensory testing (QST), and skin biopsy with evaluation of intraepidermal nerve fiber density (IENFD) were used to assess the neuropathic pain component. Results: Positive PDQ (>= 19) was obtained more frequently in patients with CDRS and LSS (26.1% and 12.0%, respectively) compared with patients with ALBP (1.6%, P<0.001). The proportion of patients with sensory loss confirmed by QST was lowest in the ALBP subgroup (23.8%) compared with CDRS (47.8%), and LSS (68.0%) subgroups (P<0.001). A reduction in IENFD was disclosed in a proportion of up to 52.0% of affected roots in patients with CRS. Discussion: Neuropathic pain is quite frequent in CRS, and QST reveals sensory loss as a frequent abnormality in patients with CRS. Using a cut-off value of 19, PDQ identified a neuropathic component in a relatively low proportion of patients with CRS. CRS may be associated with a reduction in IENFD.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 50 条
  • [1] The neuropathic component in chronic low back pain
    Foerster, M.
    Mahn, F.
    Baron, R.
    NERVENHEILKUNDE, 2012, 31 (03) : 147 - 153
  • [2] Assessment of the neuropathic component in a chronic low back pain syndrome
    Vukojevic, Zoran
    Dominovic-Kovacevic, Aleksandra
    Peric, Stojan
    Bozovic, Ivo
    Grgic, Sanja
    Basta, Ivana
    Lavrnic, Dragana
    VOJNOSANITETSKI PREGLED, 2022, 79 (01) : 25 - 30
  • [3] The neuropathic component of chronic low back pain in Douala-Cameroon
    Doualla, M.
    Luma, H. N.
    Tchaleu, B. N.
    Kwedi, F.
    Kemta, F. L.
    Memopi, M.
    Ngandeu, M. S.
    CLINICAL RHEUMATOLOGY, 2013, 32 : S123 - S124
  • [4] The neuropathic pain component among patients with chronic low back-radicular pain
    Sivas, Filiz
    Uzun, Ozlem
    Baskan, Bedriye
    Bodur, Hatice
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2018, 31 (05) : 939 - 946
  • [5] Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component"
    Bhatia, Anuj
    ANESTHESIOLOGY, 2016, 125 (01) : 255 - 256
  • [6] NEUROPATHIC PAIN COMPONENT IN PATIENTS WITH OSTEOPOROSIS AND LOW BACK PAIN
    Povoroznyuk, V.
    Shinkarenko, T.
    Pryimych, U.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S441 - S441
  • [7] The Evaluation of the Effect of Neuropathic Pain on Functional Disability in Patients with Chronic Low Back Pain
    Calik, Yalkin
    Calik, Ayca Filiz
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2015, 21 (03): : 122 - 126
  • [8] Efficacy of duloxetine versus placebo in patients with chronic low back pain and a neuropathic component
    Schukro, R. P.
    Oehmke, M.
    Reitinger, C.
    Geroldinger, A.
    Heinze, G.
    Pramhas, S.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 215 - 215
  • [9] Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component" Reply
    Pramhas, Sibylle
    Schukro, Regina P.
    Geroldinger, Angelika
    Heinze, Georg
    Kress, Hans-Georg
    ANESTHESIOLOGY, 2016, 125 (01) : 256 - 257
  • [10] The evaluation of neuropathic components in low back pain
    Rainer Freynhagen
    Ralf Baron
    Current Pain and Headache Reports, 2009, 13 : 185 - 190